Search Results - "Benator, D"

Three months of weekly rifapentine plus isoniazid is less hepatotoxic than nine months of daily isoniazid for LTBI by Bliven-Sizemore, E. E., Sterling, T. R., Shang, N., Benator, D., Schwartzman, K., Reves, R., Drobeniuc, J., Bock, N., Villarino, M. E., The TB Trials Consortium

“…SETTING: Nine months of daily isoniazid (9H) and 3 months of once-weekly rifapentine plus isoniazid (3HP) are recommended treatments for latent tuberculous…”
Get full text

Is low‐level viraemia associated with serum lipid profiles among HIV controllers? by Levy, ME, Monroe, AK, Horberg, MA, Benator, DA, Castel, AD, D'Angelo, Lawrence, Rakhmanina, Natella, Kharfen, Michael, Serlin, Michael, Kumar, Princy, Bamdad, Aria, Bezabeh, Tsedenia, Katzen Burrows, Pamela, Sapozhnikova, Alla, Temprosa, Marinella, Reamer, Susan, Younes, Naji, Byrne, Morgan, Greenberg, Alan, Jaurretche, Maria, Peterson, James, Powers Happ, Lindsey, Wilbourn, Brittany, Ma, Yan, Akselrod, Hana, Wilcox, Ronald, Rana, Sohail, Fernandez, Ricardo, Hebou, Annick, Dieffenbach, Carl, Masur, Henry, Bordon, Jose, Teferi, Gebeyehu, Ruiz, Maria Elena, Abbott, Stephen

Get full text

Xpert MTB/RIF Assay Shows Faster Clearance of Mycobacterium tuberculosis DNA with Higher Levels of Rifapentine Exposure by Jayakumar, A, Savic, R M, Everett, C K, Benator, D, Alland, D, Heilig, C M, Weiner, M, Friedrich, S O, Martinson, N A, Kerrigan, A, Zamudio, C, Goldberg, S V, Whitworth, W C, Davis, J L, Nahid, P

“…The Xpert MTB/RIF assay is both sensitive and specific as a diagnostic test. Xpert also reports quantitative output in cycle threshold (C ) values, which may…”
Get full text

Medium matters: modeling the impact of solid medium performance on tuberculosis trial sample size requirements by Johnson, M. G., Stout, J. E., Benator, D. A., Whitworth, W. C., Holland, D. P.

“…SETTING: Two-month solid medium culture conversion is a commonly used, if suboptimal, endpoint for phase 2 anti-tuberculosis treatment trials.OBJECTIVE AND…”
Get full text

Association between Acquired Rifamycin Resistance and the Pharmacokinetics of Rifabutin and Isoniazid among Patients with HIV and Tuberculosis by Weiner, Marc, Benator, Debra, Burman, William, Peloquin, Charles A., Khan, Awal, Vernon, Andrew, Jones, Brenda, Silva-Trigo, Claudia, Zhao, Zhen, Hodge, Thomas

“…Background The occurrence of acquired rifamycin resistance despite use of directly observed therapy for tuberculosis is associated with advanced human…”
Get full text

Syphilitic Hepatitis in HIV-Infected Patients: A Report of 7 Cases and Review of the Literature by Mullick, C. J., Liappis, A. P., Benator, D. A., Roberts, A. D., Parenti, D. M., Simon, G. L.

“…Background. A recent resurgence of primary and secondary syphilis has been observed in certain population groups, particularly among persons infected with…”
Get full text

Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial by Benator, Debra, Bhattacharya, Mondira, Bozeman, Lorna, Burman, William, Cantazaro, Antonino, Chaisson, Richard, Gordin, Fred, Horsburgh, C Robert, Horton, James, Khan, Awal, Lahart, Christopher, Metchock, Beverly, Pachucki, Constance, Stanton, Llewellyn, Vernon, Andrew, Villarino, M Elsa, Wang, Yong Chen, Weiner, Marc, Weis, Stephen

“…Rifapentine has a long half-life in serum, which suggests a possible treatment once a week for tuberculosis. We aimed to compare rifapentine and isoniazid once…”
Get full text

Frequency, severity and duration of immune reconstitution events in HIV-related tuberculosis by BURMAN, W, WEIS, S, WEINER, M, EI-SADR, W, VERNON, A, KHAN, A, BENATOR, D, JONES, B, SILVA, C, KING, B, LAHART, C, MANGURA, B

“…SETTING: Patients were enrolled in a prospective trial of rifabutin-based tuberculosis (TB) treatment for human immunodeficiency virus related TB…”
Get full text

O14 USE OF SOFOSBUVIR/LEDIPASVIR FIXED DOSE COMBINATION FOR TREATMENT OF HCV GENOTYPE-1 IN PATIENTS COINFECTED WITH HIV by Osinusi, A, Townsend, K, Nelson, A, Kohli, A, Gross, C, Polis, M.A, Pang, P.S, Symonds, W.T, Talwani, R, Sajadi, M.M, Hogan, J, Benator, D, Subramanian, M, Mchutchison, J, Masur, H, Kottilil, S

Get full text

Evaluation of the Drug Interaction between Rifabutin and Efavirenz in Patients with HIV Infection and Tuberculosis by Marc, Weiner, Benator, Debra, Peloquin, Charles A., Burman, William, Vernon, Andrew, Engle, Melissa, Khan, Awal, Zhao, Zhen

“…Background. Because of drug-drug interactions mediated by hepatic cytochrome P450, tuberculosis treatment guidelines recommend an increase in rifabutin from…”
Get full text

A Large-scale, Rapid Public Health Response to Rabies in an Organ Recipient and the Previously Undiagnosed Organ Donor by Wallace, R. M., Stanek, D., Griese, S., Krulak, D., Vora, N. M., Pacha, L., Kan, V., Said, M., Williams, C., Burgess, T. H., Clausen, S. S., Austin, C., Gabel, J., Lehman, M., Finelli, L. N., Selvaggi, G., Joyce, P., Gordin, F., Benator, D., Bettano, A., Cersovsky, S., Blackmore, C., Jones, S. V., Buchanan, B. D., Fernandez, A. I., Dinelli, D., Agnes, K., Clark, A., Gill, J., Irmler, M., Blythe, D., Mitchell, K., Whitman, T. J., Zapor, M. J., Zorich, S., Witkop, C., Jenkins, P., Mora, P., Droller, D., Turner, S., Dunn, L., Williams, P., Richards, C., Ewing, G., Chapman, K., Corbitt, C., Girimont, T., Franka, R., Recuenco, S., Blanton, J. D., Feldman, K. A.

“…Summary This article describes and contrasts the public health response to two human rabies cases: one organ recipient diagnosed within days of symptom onset…”
Get full text

Cholecystectomy in Patients with AIDS: Clinicopathologic Correlations in 107 Cases by French, Audrey L., Beaudet, Lisa M., Benator, Debra A., Levy, Charles S., Kass, Mary, Orenstein, Jan M.

“…The etiologic and clinical features of cholecystitis in infection due to human immunodeficiency virus (HIV) were studied retrospectively. The charts and…”
Get full text

Kikuchi disease presenting as a flu-like illness with rash and lymphadenopathy by Mugnaini, E N, Watson, T, Guccion, J, Benator, D

“…Kikuchi-Fujimoto disease (Kikuchi Disease) is a self-limited and benign systemic lymphadenitis of unknown cause, originally described by Kikuchi and Fujimoto…”
Get more information

The impact of human immunodeficiency virus infection on drug-resistant tuberculosis by Gordin, F M, Nelson, E T, Matts, J P, Cohn, D L, Ernst, J, Benator, D, Besch, C L, Crane, L R, Sampson, J H, Bragg, P S, El-Sadr, W

“…Infection with human immunodeficiency virus (HIV) has been associated with increased rates of single- and multidrug-resistant (MDR) tuberculosis in the New…”
Get more information

Nontuberculous mycobacterial infections by French, A L, Benator, D A, Gordin, F M

“…The acquired immunodeficiency syndrome (AIDS) pandemic has led to greater understanding and respect for the pathogenic potential of non-tuberculous…”
Get more information

Mycobacterium szulgai infection of the lung: case report and review of an unusual pathogen by Benator, D A, Kan, V, Gordin, F M

“…The nontuberculous mycobacteria are responsible for considerable morbidity in the immunocompromised and immunocompetent host, especially in the older patient…”
Get more information

Successful Treatment of Human Immunodeficiency Virus-Related Castleman's Disease with Interferon-α by Kumari, Pardeep, Schechter, Geraldine P., Saini, Nirmal, Benator, Debra A.

“…Multicentric Castleman's disease is an atypical lymphoproliferative disorder for which multiple chemotherapeutic regimens have been used without much success…”
Get full text

Nontuberculous mycobacteria in patients with human immunodeficiency virus infection by Benator, D A, Gordin, F M

“…Because of their often profound immune suppression, persons with HIV-infection are, increasingly, being identified as having morbidity related to mycobacteria…”
Get more information

Acquired rifamycin monoresistance in patients with HIV-related tuberculosis treated with once-weekly rifapentine and isoniazid by Vernon, Andrew, Burman, William, Benator, Debra, Khan, Awal, Bozeman, Lorna

“…Rifapentine is a cyclopentyl-substituted rifamycin whose serum half-life is five times that of rifampin. The US Public Health Service Study 22 compared a…”
Get full text

Acquired Rifamycin Resistance with Twice-Weekly Treatment of HIV-related Tuberculosis by Burman, William, Benator, Debra, Vernon, Andrew, Khan, Awal, Jones, Brenda, Silva, Claudia, Lahart, Chris, Weis, Stephen, King, Barbara, Mangura, Bonita, Weiner, Marc, El-Sadr, Wafaa, Tuberculosis Trials Consortium

“…Rifabutin was recommended in place of rifampin during treatment of HIV-related tuberculosis (TB) to facilitate concomitant potent antiretroviral therapy, but…”
Get full text